Comprehensive behavioral analysis of male ox1r−/− mice showed implication of orexin receptor-1 in mood, anxiety, and social behavior

Frontiers in Behavioral Neuroscience

Volumn 9, Issue DEC, 2015, Pages

  Abbas, Md G ^a   Shoji, Hirotaka ^b   Soya, Shingo ^a   Hondo, Mari ^a,c   Miyakawa, Tsuyoshi ^b,d   Sakurai, Takeshi ^a,c  

^a KANAZAWA UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Anxiety; Emotion; Hypocretin; Orexin; Orexin receptor 1 (OX1R); Social behavior

Indexed keywords

OREXIN 1 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DEPRESSION; EXPERIMENTAL BEHAVIORAL TEST; LOCOMOTION; MALE; MOOD; MOUSE; NONHUMAN; PREPULSE INHIBITION; PROTEIN ANALYSIS; PROTEIN FUNCTION; SENSORY GATING; SOCIAL BEHAVIOR; SOCIAL INTERACTION; STARTLE REFLEX;

EID: 84957565045     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2015.00324     Document Type: Article

References (44)

1. Adidharma, W., Leach, G., and Yan, L. (2012). Orexinergic signaling mediates light-induced neuronal activation in the dorsal raphe nucleus. Neuroscience 220, 201–207. doi:10.1016/j.neuroscience.2012.06.020.
2. Bayer, L., Eggermann, E., Serafin, M., Saint-Mleux, B., Machard, D., Jones, B., et al. (2001). Orexins (hypocretins) directly excite tuberomammillary neurons. Eur. J. Neurosci. 14, 1571–1575. doi:10.1046/j.0953-816x.2001.01777.x.
3. Brown, R. E., Sergeeva, O. A., Eriksson, K. S., and Haas, H. L. (2002). Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J. Neurosci. 22, 8850–8859.
4. Castillo-Ruiz, A., Gall, A. J., Smale, L., and Nunez, A. A. (2013). Day–night differences in neural activation in histaminergic and serotonergic areas with putative projections to the cerebrospinal fluid in a diurnal brain. Neuroscience 250, 352–363. doi:10.1016/j.neuroscience.2013.07.007.
5. Date, Y., Ueta, Y., Yamashita, H., Yamaguchi, H., Matsukura, S., Kangawa, K., et al. (1999). Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U.S.A. 96, 748–753. doi:10.1073/pnas.96.2.748.
6. Deats, S. P., Adidharma, W., Lonstein, J. S., and Yan, L. (2014). Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency. Neuroscience 272, 252–260. doi:10.1016/j.neuroscience.2014.04.069.
7. de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X. B., Foye, P. E., Danielson, P. E., et al. (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 95, 322–327. doi:10.1073/pnas.95.1.322.
8. Eriksson, K. S., Sergeeva, O., Brown, R. E., and Haas, H. L. (2001). Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J. Neurosci. 21, 9273–9279.
9. Funato, H., Tsai, A. L., Willie, J. T., Kisanuki, Y., Williams, S. C., Sakurai, T., et al. (2009). Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab. 9, 64–76. doi:10.1016/j.cmet.2008.10.010.
10. Harris, G. C., Wimmer, M., and Aston-Jones, G. (2005). A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437, 556–559. doi:10.1038/nature04071.
11. Ho, Y. C., Lee, H. J., Tung, L. W., Liao, Y. Y., Fu, S. Y., Teng, S. F., et al. (2011). Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition. J. Neurosci. 31, 14600–14610. doi:10.1523/JNEUROSCI.2671-11.2011.
12. Hondo, M., Nagai, K., Ohno, K., Kisanuki, Y., Willie, J. T., Watanabe, T., et al. (2010). Histamine-1 receptor is not required as a downstream effector of orexin-2 receptor in maintenance of basal sleep/wake states. Acta Physiol. 198, 287–294. doi:10.1111/j.1748-1716.2009.02032.x.
13. Horvath, T. L., Peyron, C., Diano, S., Ivanov, A., Aston-Jones, G., Kilduff, T. S., et al. (1999). Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol. 415, 145–159.
14. Ishida, Y., Hashiguchi, H., Takeda, R., Ishizuka, Y., Mitsuyama, Y., Kannan, H., et al. (2002). Conditioned-fear stress increases Fos expression in monoaminergic and GABAergic neurons of the locus coeruleus and dorsal raphe nuclei. Synapse 45, 46–51. doi:10.1002/syn.10086.
15. Ito, N., Yabe, T., Gamo, Y., Nagai, T., Oikawa, T., Yamada, H., et al. (2008). I.c.v. administration of orexin-A induces an antidepressive-like effect through hippocampal cell proliferation. Neuroscience 157, 720–732. doi:10.1016/j.neuroscience.2008.09.042.
16. Liu, R. J., van den Pol, A. N., and Aghajanian, G. K. (2002). Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J. Neurosci. 22, 9453–9464.
17. Lu, X. Y., Bagnol, D., Burke, S., Akil, H., and Watson, S. J. (2000). Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm. Behav. 37, 335–344. doi:10.1006/hbeh.2000.1584.
18. Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., et al. (2001). Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435, 6–25. doi:10.1002/cne.1190.
19. Mieda, M., Hasegawa, E., Kisanuki, Y. Y., Sinton, C. M., Yanagisawa, M., and Sakurai, T. (2011). Differential roles of orexin receptor-1 and-2 in the regulation of non-REM and REM sleep. J. Neurosci. 31, 6518–6526. doi:10.1523/JNEUROSCI.6506-10.2011.
20. Mieda, M., and Sakurai, T. (2013). Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. CNS Drugs 27, 83–90. doi:10.1007/s40263-012-0036-8.
21. Miyakawa, T., Leiter, L. M., Gerber, D. J., Gainetdinov, R. R., Sotnikova, T. D., Zeng, H., et al. (2003). Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 100, 8987–8992. doi:10.1073/pnas.1432926100.
22. Miyakawa, T., Yamada, M., Duttaroy, A., and Wess, J. (2001a). Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J. Neurosci. 21, 5239–5250.
23. Miyakawa, T., Yared, E., Pak, J. H., Huang, F. L., Huang, K. P., and Crawley, J. N. (2001b). Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components. Hippocampus 11, 763–775. doi:10.1002/hipo.1092.
24. Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., et al. (2004). Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 3, 287–302. doi:10.1111/j.1601-1848.2004.00076.x.
25. Nakao, A., Miki, T., Shoji, H., Nishi, M., Takeshima, H., Miyakawa, T., et al. (2015). Comprehensive behavioral analysis of voltage-gated calcium channel beta-anchoring and-regulatory protein knockout mice. Front. Behav. Neurosci. 9:141. doi:10.3389/fnbeh.2015.00141.
26. Nambu, T., Sakurai, T., Mizukami, K., Hosoya, Y., Yanagisawa, M., and Goto, K. (1999). Distribution of orexin neurons in the adult rat brain. Brain Res. 827, 243–260. doi:10.1016/S0006-8993(99)01336-0.
27. Nestler, E. J., Barrot, M., Dileone, R. J., Eisch, A. J., Gold, S. J., and Monteggia, L. M. (2002). Neurobiology of depression. Neuron 34, 13–25. doi:10.1016/S0896-6273(02)00653-0.
28. Peyron, C., Tighe, D. K., van den Pol, A. N., De Lecea, L., Heller, H. C., Sutcliffe, J. G., et al. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996–10015.
29. Sakurai, T. (2007). The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci. 8, 171–181. doi:10.1038/nrn2092.
30. Sakurai, T. (2014). The role of orexin in motivated behaviours. Nat. Rev. Neurosci. 15, 719–731. doi:10.1038/nrn3837.
31. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., et al. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573–585. doi:10.1016/S0092-8674(00)80949-6.
32. Sakurai, T., and Mieda, M. (2011). Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol. Sci. 32, 451–462. doi:10.1016/j.tips.2011.03.007.
33. Sakurai, T., Nagata, R., Yamanaka, A., Kawamura, H., Tsujino, N., Muraki, Y., et al. (2005). Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 46, 297–308. doi:10.1016/j.neuron.2005.03.010.
34. Scott, M. M., Marcus, J. N., Pettersen, A., Birnbaum, S. G., Mochizuki, T., Scammell, T. E., et al. (2011). Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav. Brain Res. 222, 289–294. doi:10.1016/j.bbr.2011.02.044.
35. Soya, S., Shoji, H., Hasegawa, E., Hondo, M., Miyakawa, T., Yanagisawa, M., et al. (2013). Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear memory consolidation. J. Neurosci. 33, 14549–14557. doi:10.1523/JNEUROSCI.1130-13.2013.
36. Steru, L., Chermat, R., Thierry, B., and Simon, P. (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85, 367–370. doi:10.1007/BF00428203.
37. Takao, K., Kobayashi, K., Hagihara, H., Ohira, K., Shoji, H., Hattori, S., et al. (2013). Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia. Neuropsychopharmacology 38, 1409–1425. doi:10.1038/npp.2013.38.
38. Takao, K., and Miyakawa, T. (2006). Light/dark transition test for mice. J. Vis. Exp. 104. doi:10.3791/104.
39. Takao, K., Toyama, K., Nakanishi, K., Hattori, S., Takamura, H., Takeda, M., et al. (2008). Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Mol. Brain 1, 1–12. doi:10.1186/1756-6606-1-11.
40. Trivedi, P., Yu, H., Macneil, D. J., Van Der Ploeg, L. H. T., and Guan, X. M. (1998). Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 438, 71–75. doi:10.1016/S0014-5793(98)01266-6.
41. Tsujimura, A., Matsuki, M., Takao, K., Yamanishi, K., Miyakawa, T., and Hashimoto-Gotoh, T. (2008). Mice lacking the kf-1 gene exhibit increased anxiety-but not despair-like behavior. Front. Behav. Neurosci. 2:4. doi:10.3389/neuro.08.004.2008.
42. Tsujino, N., and Sakurai, T. (2009). Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol. Rev. 61, 162–176. doi:10.1124/pr.109.001321.
43. Yamanaka, A., Beuckmann, C. T., Willie, J. T., Hara, J., Tsujino, N., Mieda, M., et al. (2003). Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38, 701–713. doi:10.1016/S0896-6273(03)00331-3.
44. Yamanaka, A., Tsujino, N., Funahashi, H., Honda, K., Guan, J., Wang, Q. P., et al. (2002). Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem. Biophys. Res. Commun. 290, 1237–1245. doi:10.1006/bbrc.2001.6318.